OCD Trial, Recruiting (NCT06763081)

OCD Trial, Recruiting NCT06763081 Sponsor: University of Manitoba Condition: OCD

Printed from Voxsanity (voxsanity.com.au) — NCT06763081 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ocd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must live in Manitoba
You must be between 6 and 24 years old
You must have been diagnosed with major depression, an anxiety disorder, or obsessive-compulsive disorder (OCD)
You must have taken or currently be taking an antidepressant medication from the SSRI family (such as Prozac, Zoloft, Cipralex, Celexa, Luvox, or Paxil)
[For the "Cases" group only] You must have experienced behavioural side effects while taking an SSRI, which got better after the dose was lowered or the medication was stopped
[For the "Controls" group only] You must have taken an SSRI for at least 8 weeks in a row without experiencing any side effects

Who may not be able to join:

A parent, legal guardian, or mature minor who is unable to give formal written consent for participation
Children aged 6 to 13 who are unable to give their own agreement (assent) to take part
Anyone unwilling to provide a saliva sample for genetic testing
Anyone who has been diagnosed with, or is suspected of having, ADHD (combined or hyperactive type), oppositional defiant disorder, conduct disorder, bipolar disorder, a psychotic disorder, or a pervasive developmental disorder (such as autism spectrum disorder)
Anyone who has had a liver transplant or a bone marrow (stem cell) transplant at any point in their life

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 204-318-2575

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06763081

Sponsor: University of Manitoba

Phase: Not Applicable

Status: Recruiting

Condition: OCD

Trial contact: 204-318-2575

More information: https://clinicaltrials.gov/study/NCT06763081

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must live in Manitoba
You must be between 6 and 24 years old
You must have been diagnosed with major depression, an anxiety disorder, or obsessive-compulsive disorder (OCD)
You must have taken or currently be taking an antidepressant medication from the SSRI family (such as Prozac, Zoloft, Cipralex, Celexa, Luvox, or Paxil)
[For the "Cases" group only] You must have experienced behavioural side effects while taking an SSRI, which got better after the dose was lowered or the medication was stopped
[For the "Controls" group only] You must have taken an SSRI for at least 8 weeks in a row without experiencing any side effects

Who may not be able to join:

A parent, legal guardian, or mature minor who is unable to give formal written consent for participation
Children aged 6 to 13 who are unable to give their own agreement (assent) to take part
Anyone unwilling to provide a saliva sample for genetic testing
Anyone who has been diagnosed with, or is suspected of having, ADHD (combined or hyperactive type), oppositional defiant disorder, conduct disorder, bipolar disorder, a psychotic disorder, or a pervasive developmental disorder (such as autism spectrum disorder)
Anyone who has had a liver transplant or a bone marrow (stem cell) transplant at any point in their life

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Manitoba

Registry

ClinicalTrials.gov

Start date

1 March 2025

Est. completion

31 December 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Pharmacogenomics variants associated with SSRI-induced behavioural activation; Assessment of behavioural activation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov